Ischemic Event Rates in Very-High-Risk Adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ischemic Event Rates in Very-High-Risk Adults

Published:2019-11 Issue:20 Volume:74 Page:2496-2507
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Colantonio Lisandro D.,Shannon Erin D.,Orroth Kate K.,Zaha Rebecca,Jackson Elizabeth A.,Rosenson Robert S.,Exter Jason,Mues Katherine E.,Muntner Paul

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

2. Proprotein convertase subtilisin/kexin type 9 inhibitor therapy-breakthrough in low-density lipoprotein cholesterol lowering, breakdown in value;Mark;JAMA Cardiol,2017

3. The 2018 Cholesterol Management Guidelines: topics in secondary ASCVD prevention clinicians need to know;Jia;Curr Atheroscler Rep,2019

4. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Wilson;J Am Coll Cardiol,2019

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherogenic lipid profile in patients with statin treatment after acute coronary syndrome: a real-world analysis from Chinese cardiovascular association database;Lipids in Health and Disease;2024-08-28

2. When Does Primary Prevention Encroach on Secondary Prevention?;Current Atherosclerosis Reports;2024-07-08

3. Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial;Circulation: Cardiovascular Quality and Outcomes;2024-05

4. Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings;Advances in Therapy;2024-04-30

5. Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis;Inflammation Research;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3